News

This new antibiotic may finally put a stop to some of the world’s most drug-resistant pathogens
Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.
Critically-ill kidney patients may need higher colistin antibiotic doses on dialysis days, study finds
Critically ill patients with acute kidney injury could benefit from higher doses of the antibiotic colistin on the days they ...
pharmaphorum2d
Data sets up filing of new GSK antibiotic this year
In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral ...
Biotech Finds Mid-Week Success After Meeting Primary Endpoint
A biotech company based out of Massachusetts found a tremendous amount of success mid-week after the company announced that ...
Combinatorial screening uncovers molecules that enhance antibiotics against resistant bacteria
Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...
Roche extends trials of antibiotic against resistant superbug, FT reports
Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...
Novel blood purification technique eliminates antibiotic-resistant bacteria via artificial clots
A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...
STAT4d
Pharmalittle: We’re reading about a Roche antibiotic, a gene therapy patient death, and more
Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...
India Today4d
Antibiotic for deadly superbug behind hospital infections enters final trials
An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...
Avenacy Announces Launch of Doxycycline for Injection, USP in the U.S. Market
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...
pharmaphorum4d
Roche takes new antibiotic into phase 3 for 'urgent threat'
Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...